These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23077197)

  • 1. Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis.
    Borniquel S; Jädert C; Lundberg JO
    J Nutr; 2012 Dec; 142(12):2135-40. PubMed ID: 23077197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.
    Evans NP; Misyak SA; Schmelz EM; Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutr; 2010 Mar; 140(3):515-21. PubMed ID: 20089779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-Δ
    Takagi T; Naito Y; Mizushima K; Hirai Y; Kamada K; Uchiyama K; Handa O; Ishikawa T; Itoh Y
    Arch Biochem Biophys; 2019 Nov; 677():108183. PubMed ID: 31704099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.
    Bassaganya-Riera J; Hontecillas R
    Clin Nutr; 2006 Jun; 25(3):454-65. PubMed ID: 16698153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of conjugated linoleic acid (CLA)-supplemented diet during colitis development ameliorates gut inflammation without causing steatosis in mice.
    Moreira TG; Gomes-Santos AC; Horta LS; Goncalves MC; Santiago AF; Lauar JG; Dos Reis DS; Castro-Junior AB; Lemos L; Guimarães M; Aguilar EC; Pap A; Amaral JF; Alvarez-Leite JI; Cara DC; Rezende RM; Nagy L; Faria AMC; Maioli TU
    J Nutr Biochem; 2018 Jul; 57():238-245. PubMed ID: 29800810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.
    Bassaganya-Riera J; Reynolds K; Martino-Catt S; Cui Y; Hennighausen L; Gonzalez F; Rohrer J; Benninghoff AU; Hontecillas R
    Gastroenterology; 2004 Sep; 127(3):777-91. PubMed ID: 15362034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally Administered CLA Ameliorates DSS-Induced Colitis in Mice via Intestinal Barrier Improvement, Oxidative Stress Reduction, and Inflammatory Cytokine and Gut Microbiota Modulation.
    Chen Y; Yang B; Ross RP; Jin Y; Stanton C; Zhao J; Zhang H; Chen W
    J Agric Food Chem; 2019 Dec; 67(48):13282-13298. PubMed ID: 31690068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.
    Bassaganya-Riera J; Viladomiu M; Pedragosa M; De Simone C; Carbo A; Shaykhutdinov R; Jobin C; Arthur JC; Corl BA; Vogel H; Storr M; Hontecillas R
    PLoS One; 2012; 7(2):e31238. PubMed ID: 22363592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
    Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
    Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells.
    Moreira TG; Horta LS; Gomes-Santos AC; Oliveira RP; Queiroz NMGP; Mangani D; Daniel B; Vieira AT; Liu S; Rodrigues AM; Gomes DA; Gabriely G; Ferreira E; Weiner HL; Rezende RM; Nagy L; Faria AMC
    Mucosal Immunol; 2019 Jan; 12(1):188-199. PubMed ID: 30279515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C iota in the intestinal epithelium protects against dextran sodium sulfate-induced colitis.
    Calcagno SR; Li S; Shahid MW; Wallace MB; Leitges M; Fields AP; Murray NR
    Inflamm Bowel Dis; 2011 Aug; 17(8):1685-97. PubMed ID: 21744423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat.
    Poulsen SS; Kissow H; Hare K; Hartmann B; Thim L
    Regul Pept; 2005 Mar; 126(3):163-71. PubMed ID: 15664663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow.
    Judd LM; Chalinor HV; Walduck A; Pavlic DI; Däbritz J; Dubeykovskaya Z; Wang TC; Menheniott TR; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(1):G12-24. PubMed ID: 25324506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chen Y; Chen H; Ding J; Stanton C; Ross RP; Zhao J; Zhang H; Yang B; Chen W
    J Agric Food Chem; 2021 Dec; 69(48):14593-14608. PubMed ID: 34843239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH; Murakami A; Tanaka T; Ohigashi H
    Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy protein diet, but not Lactobacillus rhamnosus GG, decreases mucin-1, trefoil factor-3, and tumor necrosis factor-α in colon of dextran sodium sulfate-treated C57BL/6 mice.
    Jiang H; Przybyszewski J; Mitra D; Becker C; Brehm-Stecher B; Tentinger A; MacDonald RS
    J Nutr; 2011 Jul; 141(7):1239-46. PubMed ID: 21593350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of total triterpenoids of Chaenomeles speciosa on PPARγ/SIRT1/NF-κBp65 signaling pathway and intestinal mucosal barrier of ulcerative colitis induced by DSS in mice].
    Xiong XJ; Li XM; He YM; Li XQ; Xu HY; Feng ML; He HB; Zhang JH; Zhu S; Komatsu Katsuko ; Zou K
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4295-4304. PubMed ID: 30583632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice.
    Kjellev S; Thim L; Pyke C; Poulsen SS
    Dig Dis Sci; 2007 Apr; 52(4):1050-9. PubMed ID: 17342398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
    Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.